Tracon Pharmaceuticals Announces Up To $30M Non-Recourse Non-Dilutive Financing Related To Arbitration Award Decision Expected In Q1 2023
Amount Raised
$30 Million
Round Type
Grant
Description
TRACON Pharmaceuticals (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with other life science companies, today announced entry into an up to $30 million non-recourse financing agreement.
Who else raised in Pharmaceutical and Biotechnology around the same time
Companies in the same sectors as TRACON that raised within 45 days of this round, from Fundz verified event records.
- CUREMARK LLC raised $1.3M (Seed) on January 30, 2023.
- Inhibikase Therapeutics raised $4.2M (Seed) on January 27, 2023.
- Liquidia raised an undisclosed amount (Debt Financing) on January 9, 2023.
- HighTide Therapeutics raised $107M (Series C) on January 5, 2023.
- Madrigal Pharmaceuticals raised $300M (Funding Round) on December 21, 2022.
- ExPLoRNA Therapeutics raised an undisclosed amount (Funding Round) on December 7, 2022.
Who to call at TRACON, and when
A new round usually means TRACON is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day TRACON raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at TRACON, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at TRACON. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment TRACON raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
TRACON raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.